Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Finnair Plc - Managers' transactions - Pienimäki

Finnair Plc, Managers’ Transactions, 3 November 2020 at 09:02 am EET____________________________________________ Person subject to the notification requirementName: Pienimäki, TomiPosition: Other senior managerIssuer: Finnair PlcLEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATIONReference number: 213800SB6EOB8SSK9W63_20201102132545_148____________________________________________ Transaction date: 2020-10-30Venue not applicableInstrument type: SHAREISIN: FI0009003230Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVEFurther details:

Finnair Plc - Managers' transactions - Orvér

Finnair Plc, Managers’ Transactions, 3 November 2020 at 09:01 am EET____________________________________________ Person subject to the notification requirementName: Orvér, MatsPosition: Other senior managerIssuer: Finnair PlcLEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATIONReference number: 213800SB6EOB8SSK9W63_20201102132545_147____________________________________________ Transaction date: 2020-10-30Venue not applicableInstrument type: SHAREISIN: FI0009003230Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVEFurther details: Bonus

Ahlstrom-Munksjö Oyj - Managers' Transactions (Johannes Gullichsen)

AHLSTROM-MUNKSJÖ OYJ, MANAGERS’ TRANSACTION RELEASE November 3, 2020 at 09:00 EET ____________________________________________ Person subject to the notification requirement Name: Antti Ahlström Perilliset Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Gullichsen, Johannes Position: Member of the Board Issuer: Ahlstrom-Munksjö Oyj LEI: 213800F2MJ5Z2TAQ1726 Notification type: INITIAL NOTIFICATION Reference number: 213800F2MJ5Z2TAQ1726_20201102094931_4 ____________________________

Troax AB acquires Natom Logistic

Hillerstorp 3rd of November 2020, 08:00 CET   Troax AB, which is a part of the Troax Group, has entered into an agreement to acquire all outstanding shares in the Polish company Natom Logistic sp.  z o.o (“Natom”)Natom is a leading manufacturer of warehouse equipment on the European market. It is headquartered in Chocicza, Poland, with a secondary operation in Koscian, Poland.  Natom was founded in 2006 by Tomasz Świątek and he has over the years developed Natom from a local startup to a leading manufacturer within its segment in Europe. Natom has 180 employees and sales of

Peab builds swimming pool facility in Kävlinge

Peab has been commissioned to build a new swimming pool facility in central Kävlinge. The customer is KKB Fastigheter AB and the contract is worth SEK 292 million.The pool facility will be called Harjagersbadet and include a 25x25 meter pool, two training pools, a children’s playground with a water slide, a relax area and a gym. The entire swimming pool facility will be around 7,100 m2. “This is an important and great community investment for the residents of Kävlinge Municipality and naturally we are proud to contribute. We hope the new pool facility will be a hub for training and

Moberg Pharma’s Interim report for July 2019 - September 2020 to be published on November 10 - Invitation to teleconference

STOCKHOLM, November 3[rd], 2020 - On November 10[th], 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for July 2019 - September 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.The teleconference will be hosted by Moberg Pharmas’s CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English. Date:             November 10[th], 2020Time:             3:00 pm (CET) To participate in the conference, please dial in on any number below before the

Inzile signs cooperation agreement with Eways regarding charging infrastructure

Inzile has signed a cooperation agreement with Eways regarding marketing and sales of charging infrastructure. The purpose of the collaboration is to offer customers who purchase Inzile’s electric truck the opportunity to also procure the necessary charging infrastructure.Inzile has signed a cooperation agreement with Eways regarding marketing and sales of charging infrastructure. Eways is an independent charging operator that markets, sells and installs charging infrastructure with associated services for electric vehicles. Delivery and installation of the charging stations takes place

Nordic Mining ASA (OAX:NOM) - Interim report per 30 September 2020

Please find enclosed Nordic Mining’s interim report and company presentation for the third quarter of 2020. The interim report and company updates will be presented digitally today, Tuesday 3 November 2020 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast at:  https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_5 You will have the opportunity to post questions online throughout the webcast session. Important events in the third quarter of 2020 and year to date: CORPORATE Fully financed for ongoing DFS update and

Trading of own shares as part of employee’s savings scheme

SpareBank 1 SR-Bank ASA has on 2 November 2020 purchased 30.000 own shares at an average price of NOK 77,581. Total holdings of own shares after the purchase is 81.532 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s savings scheme for employees. For more information about the saving scheme reference is made to the stock exchange notice dated 12 December 2019, and the stock exchange notice dated 24 April 2020.

SBB, Interim Report January – September 2020: Profit after tax SEK 4.15 per class A and B ordinary share

SAMHÄLLSBYGGNADSBOLAGET I NORDEN AB (PUBL): Interim Report January – September 2020 in brief: · Rental income increased to SEK 3,868m (1,400). · The operating surplus increased to SEK 2,669m (903). · Cashflow from operating activities before changes in working capital was SEK 1,590m (450). · Profit before tax increased to SEK 6,142m (1,526), of which: · Profit from property management is included in the amount of SEK 1,601m (508). The profit from property management includes costs for early repayment of loans and other non-recurring costs of SEK -206m (-130). ·

The Subscription Period in Clavister’s Rights Issue Commences

Today is the first day of subscription period in Clavister AB’s (“Clavister” or the “Company”) rights issue resolved by the extraordinary general meeting on 22 October 2020 (the "Rights Issue"). The general public, with the exception of jurisdictions stated in the section “Important information” below, also has the opportunity to subscribe for shares without subscription rights.Clavister is carrying out the Rights Issue amounting approximately MSEK 149.8 before deductions for costs related to the Rights Issue, primarily for the purpose of strengthening sales growth. Clavister has received

INTERIM REPORT, January-September 2020

Continued growth with a strong financial positionThird quarter of 2020 · Consolidated net sales increased by 2 percent to SEK 916 m (901), of which organic growth amounted to 5 percent · Net sales in Product & Solutions amounted to SEK 694 m (671) and in Installation Services to SEK 249 m (262) · Gross profit increased to SEK 282 m (243), Gross margin increased to 30.8% (27.0%) · EBITDA increased to SEK 164 m (137), EBITDA margin increased to 17.9% (15.3%) · Operating profit (EBIT) increased to SEK 133 m (109), EBIT margin increased to 14.6% (12.1%) · ROCE increased to

Extraordinary General Meeting in Oncopeptides AB (publ)

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, (“Oncopeptides” or the “Company”) are hereby given notice to attend the Extraordinary General Meeting on Friday 4 December 2020.Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Extraordinary General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Extraordinary General

Award of Phase 1 Rig Contract to Noble Corporation

3 November 2020   Independent Oil and Gas plc   Award of Phase 1 Rig Contract to Noble Corporation   Independent Oil and Gas plc ("IOG" or "the Company"), (AIM: IOG.L), the UK gas company targeting high returns via an infrastructure-led hub strategy, as operator of its joint venture with CalEnergy Resources (UK) Ltd, is pleased to announce that it has awarded the rig contract for its Core Project Phase 1 to a subsidiary of Noble Corporation ("Noble"). This follows a competitive selection process by IOG's drilling and contracting teams, assisted by well management

Building a safe & sustainable future: Normet launches a completely new L-size equipment offering with Stage V engines and new cabin

Normet has launched its new L-size equipment offering with Stage V emission class engines on 3[rd] of November 2020. Stage V engine technology reduces the diesel particles significantly providing cleaner working environment for the people underground.Improving Safety and Comfort with a new cabin and platform L-series Stage V offering is equipped with Normet’s new FOPS/ROPS (Falling-Objective Protective Structure/Roll-Over Protective Structure) approved front cabin, which offers superior visibility, great ergonomics and low noise level, ensuring safe and comfortable driving. The

Solid performance across strategic brands with 19% growth in the first nine months of 2020; financial guidance range for 2020 narrowed

HIGHLIGHTS Revenue reached DKK 13,397 million in the first nine months of 2020, a growth of 6% (6% in local currencies) compared to 2019 with growth from all regions. The newest product in the portfolio, Vyepti[®], continues to pick up momentum doubling revenue compared to the second quarter of the year, despite the pandemic’s negative impact on HCP administered drugs. Cash flow saw a substantial improvement from same period last year driven by the strong operational performance. Growth continues to be driven by patient uptake due to the efficacy and reliability of the products in the

Scandic to take over hotel at Stockholm Arlanda Airport

Scandic has signed an agreement to take over the operation of a 150-room hotel at Arlandastad in close proximity to Stockholm Arlanda Airport and with direct access to the new international meeting and event center, Scandinavian XPO.Scandic has reached an agreement with property owner Arlandastad Holding regarding a 15-year lease agreement for the former First Hotel Arlanda. The hotel was built in 2015 but has been closed in recent months following the bankruptcy of the hotel operator. Scandic expects to open the hotel on January 10, 2021 under the name Scandic Arlandastad. Since the

Nyfosa acquires properties at a value of MSEK 76

Nyfosa has acquired two properties comprising of logistics and warehouses situated in Hässleholm, at a value of MSEK 76. The properties complement Nyfosa’s current portfolio in the region and contributes with strong cash flows.The two properties comprise a total area of 10,398 square meters with a rental value of approximately MSEK 6.9. The largest tenant is Postnord Sverige and the average remaining contract length is 4.9 years. The properties are fully let. Closing is planned for November 2020. “It is important for us to also go through with this kind of smaller acquisitions. In this

Scandic’s interim report Q3 2020 – Slow recovery

Third quarter in summary · Net sales decreased by 60 percent to 2,085 MSEK (5,195). · Occupancy was 36 percent, (75.5) less than half of what it was during Q3 2019. · Adjusted EBITDA was 90 MSEK (823). The decrease in earnings was mitigated by direct government support of 371 MSEK as well as low operating costs. · Excluding the effects of IFRS 16 and items affecting comparability, earnings per share amounted to -0.77 SEK (4.28). · Items affecting comparability amounted to -70 MSEK, related to staff reductions in Norway and Denmark. · At the end of the quarter, Scandic’s

Third quarter and nine months report - 30 September 2020

Third quarter 2020 (second quarter 2020) · Production from Blocks 3&4, Oman, at 10,651 barrels per day (10,597 barrels per day) · Revenue and other income of MUSD 20.4 (MUSD 21.1) · EBITDA of MUSD 9.5 (MUSD 8.7) · Net result of MUSD -2.1 (MUSD -3.9) · Earnings per share amounted to USD -0.06 (USD -0.12) · Free cash flow MUSD -11.7 (MUSD 0.2) · Net cash MUSD 48.0 (MUSD 59.8) · Free cash flow, before acquisitions, is expected to be positive for the fourth quarter and full year 2020 · Tethys Oil entered into an Exploration and Production Sharing Agreement (EPSA) with

Sinch AB (publ): Interim Report, January – September 2020

Interim Report, January – September 2020 July – September 2020 · Net sales increased by 46 percent to SEK 1,777.7 million (1,216.4). Organic growth was 35 percent. · Gross profit increased by 40 percent to SEK 480.6 million (343.6). Organic growth was 24 percent. · Adjusted EBITDA1 increased by 53 percent to SEK 226.0 million (147.6). · Adjusted EBIT2 amounted to SEK 210.7 million (131.5). · Profit after tax for the quarter amounted to SEK 96.4 million (68.7). · Diluted earnings per share were SEK 1.56 (1.27). January – September 2020 · Net sales increased by

AcuCort is granted a patent in China for the drug ISICORT®

AcuCort AB (Spotlight Stock Market: ACUC) today announced that the China National Intellectual Property Administration has granted the company’s patent application for its drug ISICORT®. The company has an active patent strategy covering all major geographic markets, including China.ISICORT® is a thin, fast-dissolving and user-friendly oral film for the treatment of acute and severe allergic reactions, for croup in children and chemotherapy-induced nausea and vomiting (CINV). The fast-dissolving oral film contains the glucocorticoid dexamethasone which is a well-known, often used and well-

The importance of good neighbours in catalysis

Are you affected by your neighbours? So are nanoparticles in catalysts. New research from Chalmers University of Technology, Sweden, published in the journals Science Advances and Nature Communications, reveals how the nearest neighbours determine how well nanoparticles work in a catalyst. “The long-term goal of the research is to be able to identify ‘super-particles’, to contribute to more efficient catalysts in the future. To utilise the resources better than today, we also want as many particles as possible to be actively participating in the catalytic reaction at the same

Observe Medical ASA: Interim report third quarter 2020

Oslo, November 3rd, 2020 - Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes to improved clinical results for patients and increased efficiency for the health care system. For us, it is now paramount to roll the Sippi® system out to hospitals, and through the acquisition of Sylak AB,

There are no items matching the current filter
There are no more items matching the current filter
Back to top